Literature DB >> 19379743

BS69 negatively regulates the canonical NF-kappaB activation induced by Epstein-Barr virus-derived LMP1.

Osamu Ikeda1, Yuichi Sekine, Akihiro Mizushima, Kenji Oritani, Teruhito Yasui, Masahiro Fujimuro, Ryuta Muromoto, Asuka Nanbo, Tadashi Matsuda.   

Abstract

Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) activates NF-kappaB signaling pathways through the two C-terminal regions, CTAR1 and CTAR2. BS69 has previously been shown to be involved in LMP1-induced c-Jun N-terminal kinase activation through CTAR2 by interacting with tumor necrosis factor (TNFR) receptor-associated factor 6. In the present study, our manipulation of BS69 expression clearly indicates that BS69 negatively regulates LMP1-mediated NF-kappaB activation and up-regulates IL-6 mRNA expression and IkappaB degradation. Our immunoprecipitation experiments suggest that BS69 decreases complex formation between LMP1 and TNFR-associated death domain protein (TRADD).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19379743     DOI: 10.1016/j.febslet.2009.04.022

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  The A20 deubiquitinase activity negatively regulates LMP1 activation of IRF7.

Authors:  Shunbin Ning; Joseph S Pagano
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

2.  Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).

Authors:  Kelly M Arcipowski; Laura L Stunz; John P Graham; Zachary J Kraus; Tony J Vanden Bush; Gail A Bishop
Journal:  J Biol Chem       Date:  2011-01-24       Impact factor: 5.157

Review 3.  Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.

Authors:  Abhik Saha; Rajeev Kaul; Masanao Murakami; Erle S Robertson
Journal:  Cancer Biol Ther       Date:  2010-11-15       Impact factor: 4.742

4.  A miR-19 regulon that controls NF-κB signaling.

Authors:  Michael P Gantier; H James Stunden; Claire E McCoy; Mark A Behlke; Die Wang; Maria Kaparakis-Liaskos; Soroush T Sarvestani; Yuan H Yang; Dakang Xu; Sinéad C Corr; Eric F Morand; Bryan R G Williams
Journal:  Nucleic Acids Res       Date:  2012-06-07       Impact factor: 16.971

5.  Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivo.

Authors:  Adele Hannigan; Asif M Qureshi; Colin Nixon; Penelope M Tsimbouri; Sarah Jones; Adrian W Philbey; Joanna B Wilson
Journal:  Mol Cancer       Date:  2011-02-03       Impact factor: 27.401

6.  Mga Modulates Bmpr1a Activity by Antagonizing Bs69 in Zebrafish.

Authors:  Xiaoyun Sun; Ji Chen; Yanyong Zhang; Mumingjiang Munisha; Scott Dougan; Yuhua Sun
Journal:  Front Cell Dev Biol       Date:  2018-09-28

7.  In silico evidence of de novo interactions between ribosomal and Epstein - Barr virus proteins.

Authors:  Edmund Ui-Hang Sim; Shruti Prashant Talwar
Journal:  BMC Mol Cell Biol       Date:  2019-08-15

8.  Increased association between Epstein-Barr virus EBNA2 from type 2 strains and the transcriptional repressor BS69 restricts EBNA2 activity.

Authors:  Rajesh Ponnusamy; Ritika Khatri; Paulo B Correia; C David Wood; Erika J Mancini; Paul J Farrell; Michelle J West
Journal:  PLoS Pathog       Date:  2019-07-08       Impact factor: 6.823

9.  Chicken gga-miR-19a Targets ZMYND11 and Plays an Important Role in Host Defense against Mycoplasma gallisepticum (HS Strain) Infection.

Authors:  Qingchang Hu; Yabo Zhao; Zaiwei Wang; Yue Hou; Dingren Bi; Jianjun Sun; Xiuli Peng
Journal:  Front Cell Infect Microbiol       Date:  2016-09-14       Impact factor: 5.293

10.  Gga-miR-19b-3p Inhibits Newcastle Disease Virus Replication by Suppressing Inflammatory Response via Targeting RNF11 and ZMYND11.

Authors:  Yu Chen; Wen Liu; Haixu Xu; Jingjing Liu; Yonghuan Deng; Hao Cheng; Tiansong Zhan; Xiaolong Lu; Tianxing Liao; Lili Guo; Shanshan Zhu; Yuru Pei; Jiao Hu; Zenglei Hu; Xiaowen Liu; Xiaoquan Wang; Min Gu; Shunlin Hu; Xiufan Liu
Journal:  Front Microbiol       Date:  2019-08-27       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.